Treat-to-target Prednisolon Taper in Patients With Polymyalgia Rheumatica
Condition(s):Polymyalgia RheumaticaLast Updated:February 1, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Polymyalgia RheumaticaLast Updated:February 1, 2023Recruiting
Condition(s):Recurrent MiscarriageLast Updated:December 1, 2023Recruiting
Condition(s):Esophageal Neoplasms; Esophagus StenosisLast Updated:March 16, 2023Recruiting
Condition(s):Multiple SclerosisLast Updated:January 9, 2023Recruiting
Condition(s):Recurrent Miscarriage; Recurrent Pregnancy Loss; Habitual Abortion; Miscarriage; Fertility DisordersLast Updated:January 31, 2024Recruiting
Condition(s):Total Knee ArthroplastyLast Updated:December 13, 2023Recruiting
Condition(s):Acute GoutLast Updated:February 9, 2024Recruiting
Condition(s):Methylprednisolone; Thoracic Endovascular Repair; Post-implantation Syndrome; Type B Aortic DissectionLast Updated:April 27, 2022Not yet recruiting
Condition(s):Healthy VolunteersLast Updated:April 12, 2022Recruiting
Condition(s):Ulcerative Colitis ChronicLast Updated:April 22, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.